Téoule Patrick, Birgin Emrullah, Mertens Christina, Schwarzbach Matthias, Post Stefan, Rahbari Nuh N, Reißfelder Christoph, Ronellenfitsch Ulrich
Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Department of General and Visceral Surgery, Städtisches Klinikum Karlsruhe, Moltkestr.90, 76133 Karlsruhe, Germany.
Cancers (Basel). 2020 Feb 13;12(2):434. doi: 10.3390/cancers12020434.
(1) : Oncological gastrectomy requires complex multidisciplinary management. Clinical pathways (CPs) can potentially facilitate this task, but evidence related to their use in managing oncological gastrectomy is limited. This study evaluated the effect of a CP for oncological gastrectomy on process and outcome quality. (2) : Consecutive patients undergoing oncological gastrectomy before ( = 64) or after ( = 62) the introduction of a CP were evaluated. Assessed parameters included catheter and drain management, postoperative mobilization, resumption of diet and length of stay. Morbidity, mortality, reoperation and readmission rates were used as indicators of outcome quality. (3) : Enteral nutrition was initiated significantly earlier after CP implementation (5.0 vs. 7.0 days, < 0.0001). Readmission was more frequent before CP implementation (7.8% vs. 0.0%, = 0.05). Incentive spirometer usage increased following CP implementation (100% vs. 90.6%, = 0.11). Mortality, morbidity and reoperation rates remained unchanged. (4) : After implementation of an oncological gastrectomy CP, process quality improved, while indicators of outcome quality such as mortality and reoperation rates remained unchanged. CPs are a promising tool to standardize perioperative care for oncological gastrectomy.
(1):肿瘤性胃切除术需要复杂的多学科管理。临床路径(CPs)可能有助于完成这项任务,但关于其在肿瘤性胃切除术管理中应用的证据有限。本研究评估了肿瘤性胃切除术临床路径对过程质量和结局质量的影响。(2):对在引入临床路径之前(n = 64)或之后(n = 62)接受肿瘤性胃切除术的连续患者进行评估。评估参数包括导管和引流管理、术后活动、饮食恢复和住院时间。发病率、死亡率、再次手术率和再入院率用作结局质量指标。(3):实施临床路径后肠内营养开始时间显著提前(5.0天对7.0天,P < 0.0001)。实施临床路径前再入院更频繁(7.8%对0.0%,P = 0.05)。实施临床路径后激励肺活量计使用增加(100%对90.6%)= 0.11)。死亡率、发病率和再次手术率保持不变。(4):实施肿瘤性胃切除术临床路径后,过程质量得到改善,而死亡率和再次手术率等结局质量指标保持不变。临床路径是规范肿瘤性胃切除术围手术期护理的有前景工具。